Alert detail

LCD L36180: MolDX: Genetic Testing for BCR-ABL Negative Myeloproliferative Disease — Noridian

Policy ID: LCD-L36180Specialty: HematologyAdded: 6/5/2026Effective: July 6, 2023lcd
High

What changed

New genetic testing guidelines announced by Noridian.

Who’s affected: Hematology billing teams · Effective: July 6, 2023

Affected codes

Primary source: View the official CMS/MAC document ↗

Get the action steps and full analysis

This change affects 16 billing codes.

The full analysis, the revision comparison and the as-of-date version of this policy are what a partner packet carries. The source document above is free and always will be.